✦ LIBER ✦

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

✍ Scribed by Anthony V D'Amico; Ming-Hui Chen; Mario de Castro; Marian Loffredo; David S Lamb; Allison Steigler; Philip W Kantoff; James W Denham

Book ID: 117785818
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 145 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70295-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Surrogate Endpoints for Prostate Can

Re: Surrogate Endpoints for Prostate Cancer-Specific Mortality After Radiotherapy and Androgen Suppression Therapy in Men With Localised or Locally Advanced Prostate Cancer: An Analysis of Two Randomised Trials

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB

Locally advanced prostate cancer: Bioche

Locally advanced prostate cancer: Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

✍ Bernardo Rocco; Epifanio Scardino; Ottavio de Cobelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

I n the article by Bruchovsky et al., 1 intermittent androgen sup- pression was evaluated in patients with clinically locally advanced prostate cancer who developed biochemical disease recurrence after radiotherapy. We consider it to be of utmost important to improve currently existing knowledge re

Locally advanced prostate cancer—biochem

Locally advanced prostate cancer—biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

✍ Nicholas Bruchovsky; Laurence Klotz; Juanita Crook; S. Larry Goldenberg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Commentary on “Surrogate endpoints for p

Commentary on “Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: An analysis of 2 randomized trials.” A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA

✍ Trump, Donald L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Quality of Life, Morbidity, and Mortalit

Quality of Life, Morbidity, and Mortality Results of a Prospective Phase II Study of Intermittent Androgen Suppression for Men with Evidence of Prostate-Specific Antigen Relapse After Radiation Therapy for Locally Advanced Prostate Cancer

✍ Nicholas Bruchovsky; Laurence Klotz; Juanita Crook; Norman Phillips; Jonas Abers 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 135 KB